ArticleCureus2024
Safety and Efficacy of Phacoemulsification With Trabecular Microbypass Stent W Implantation in Primary Angle-Closure Glaucoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One-Year Outcomes of Phacoemulsification Combined with Trabecular Micro-Bypass Stent Implantation and Goniosynechialysis in Primary Angle Closure Glaucoma.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Investigation of the safety and efficacy of phacoemulsification with trabecular microbypass Stent W implantation in patients with primary angle-closure glaucoma (PACG). Methods Between August and December of 2023, this prospective study evaluated PACG patients who underwent phacoemulsification with iStent inject W implantation. All patients were 18 years and older and were monitored for 6 months after surgery. Changes in intraocular pressure (IOP) and the number of glaucoma medications at 6 months after the surgery were defined as the primary endpoint, while the safety of the iStent inject W implantation in these patients was the secondary endpoint. Results Of the six patients in the study, one was male and five were female, with patient ages ranging from 62 to 83 years. Pre- and postoperative IOP (at 6 months) ranged from 12 to 18 mmHg and 9 to 17 mmHg, respectively, with only one patient exhibiting an increase in the IOP from 12 to 17 mmHg. The number of glaucoma medications decreased in all but one case at six months postoperatively. Neither hyphema nor an IOP spike was observed in the present study. There was no evidence of iStent inject W occlusion or malposition at six months postoperatively in any of the cases. Conclusion In patients with PACG, phacoemulsification with trabecular microbypass Stent W implantation was demonstrated to be a safe and effective procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.